Article
Cystic Fibrosis: Highly Effective Targeted Therapeutics and the Impact on Sex and Racial Disparities.
The Medical clinics of North America - 1 Nov 2022
Montemayor Kristina, Jain Raksha
Abstract excerpt
People with Cystic Fibrosis (CF) are living longer and healthier lives due in part to new therapies, called Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulators. However, disparities in outcomes still exist, with females demonstrating a shorter life expectancy than males; this is opposed to the typical female versus male life expectancy in the general United States population. In addition,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
